American Society Of Clinical Oncology

Asco: More Than One In Five Millennials Use E-cigarettes

FRIDAY, Sept. 27, 2019 -- One in eight U.S. adults report using electronic cigarettes regularly, according to the American Society of Clinical Oncology's 2019 Cancer Opinions Survey. The survey, conducted online by The Harris Poll, was...
Related topics: American Cancer Society, Cancer, Oncology, Polls

Read More →

American Society Of Clinical Oncology: Science Communications Administrator

Commensurate with experience : American Society of Clinical Oncology: Cancer strikes more than 10 million people worldwide each year. As the leading medical society representing doctors who care for people with cancer... Alexandria, Virginia
Related topics: American Cancer Society, Cancer, Oncology

Read More →

Astro Issues Guideline For Radiation Tx In Pancreatic Cancer

THURSDAY, Sept. 19, 2019 -- In a new American Society for Radiation Oncology clinical practice guideline, published in the September-October issue of Practical Radiation Oncology, recommendations are presented for radiation treatment of pancreatic...
Related topics: Pancreatic Cancer, American Cancer Society, Cancer, Oncology

Read More →

Radiation Oncology Research And Clinical Trial Results To Be Featured At Astro's Annual Meeting In...

The American Society for Radiation Oncology (ASTRO) announced today the top-rated studies to be highlighted in the press program for the 2019 ASTRO Annual Meeting. Researchers will present their findings in three news briefings being held September...
Related topics: Cancer, Oncology, Medical Research, Clinical Trials

Read More →

Alternative Cancer Therapies And The Promise Of False Hope

How do you respond when patients with a good prognosis want to delay chemotherapy to try an anticancer diet for a few months or visit an unregulated clinic for unproven therapies? I’m asking because of an alarming finding of ASCO’s 2018...
Related topics: Cancer, Oncology, Chemotherapy, Diet

Read More →

American Society For Radiation Oncology (astro) To Host Annual Meeting In Chicago, September 15-18

The American Society for Radiation Oncology (ASTRO) will host its 61st Annual Meeting at McCormick Place in Chicago, September 15-18, 2019. The meeting will feature updates on clinical trials, cancer research and new approaches that involve...
Related topics: American Cancer Society, Cancer, Oncology, Clinical Trials, Medical Research

Read More →

Healthcare Investor Brad Loncar Breaks Down Asco 2019's Winners And Losers

Earlier this month, industry watchers gathered at the annual American Society of Clinical Oncology (ASCO) conference to discuss the latest research in the battle against cancer. The event is one of the most anticipated of the year for researchers...
Related topics: American Cancer Society, Cancer, Oncology, Medical Research

Read More →

Hashtag Medicine: Abstract Tweeted At Asco Ignites Debate

A tweet about how male and female presenters are introduced differently at ASCO meetings was divisive. Medscape Medical News
Related topics: Debate

Read More →

Asco Poster Rounds: Peptide Vaccine Yields Mixed Results In Prostate Ca

(MedPage Today) -- Also: novel BiTE immunotherapeutic shows promise; pembrolizumab combinations moving forward in mCRPC
Related topics: Vaccines

Read More →

More Practice-informing Data From Asco

(MedPage Today) -- News, features, and commentary about cancer-related issues
Related topics: Cancer, Oncology

Read More →

American Society Of Clinical Oncology, May 31-june 4

The 55th Annual Meeting of the American Society of Clinical Oncology The annual meeting of the American Society of Clinical Oncology was held from May 31 to June 4 in Chicago and attracted approximately 20,000 participants from around the world,...
Related topics: Cancer, Oncology

Read More →

Was Asco Quieter For Big Drug/biotech Stocks This Year?

The world of cancer research is seeing huge developments and companies are taking great strides to find treatments for a variety of cancers.The five-day long ASCO conference, which is basically the most important annual cancer research event, held...
Related topics: Cancer, Oncology, Medical Research

Read More →

Asco: Enzalutamide Beneficial In Metastatic Prostate Cancer

WEDNESDAY, June 5, 2019 -- For men with metastatic, hormone-sensitive prostate cancer receiving testosterone suppression, enzalutamide is associated with significantly longer progression-free and overall survival, according to a study published...
Related topics: Prostate Cancer, Cancer, Oncology, Hormones, Medical Research

Read More →

Asco: Combo Regimen Effective In Cll With Coexisting Conditions

TUESDAY, June 4, 2019 -- Venetoclax-obinutuzumab is associated with longer progression-free survival than chlorambucil-obinutuzumab among patients with untreated chronic lymphocytic leukemia (CLL) and coexisting conditions, according to a study...
Related topics: Leukemia, Medical Research

Read More →

Here's Why Nektar Therapeutics Is Soaring Today

Shares of Nektar Therapeutics (NASDAQ: NKTR) rose more than 13% today after it announced an update for one of its most promising clinical programs at the 2019 American Society of Clinical Oncology (ASCO) meeting. A combination therapy comprising...
Related topics: Nasdaq, Cancer, Oncology

Read More →

Immunotherapy Keeps 87-year-old Man On The Job

Five-year survival data for pembrolizumab patients with advanced non-small cell lung cancer were presented June 1 at the 2019 ASCO Annual Meeting, May 31-June 4, in Chicago. The study results showed a marked improvement over 5-year survival rates in...
Related topics: Lung Cancer, Cancer, Oncology, Medical Research

Read More →

Immunotherapy Keeps 87-year-old Man On The Job

Five-year survival data for pembrolizumab patients with advanced non-small cell lung cancer were presented June 1 at the 2019 ASCO Annual Meeting, May 31-June 4, in Chicago. The study results showed a marked improvement over 5-year survival rates in...
Related topics: Lung Cancer, Cancer, Oncology, Medical Research

Read More →

Asco: Pembrolizumab Noninferior To Chemo In Advanced Gastric Cancer

MONDAY, June 3, 2019 -- Pembrolizumab is noninferior to chemotherapy for overall survival among patients with programmed death ligand 1, human epidermal growth factor receptor 2-negative, advanced gastric or gastroesophageal junction cancer,...
Related topics: Chemotherapy, Cancer, Oncology

Read More →

Why Genocea’s Neoantigen Treatment Is Such A Big Hit At Asco

Here is why Genocea Biosciences is one of the big winners from the annual meeting of the American Society of Clinical Oncology (ASCO).
Related topics: Cancer, Oncology

Read More →

2 Mayo Clinic Studies Examine Discrimination, Bias In Health Care Organizations

Two studies that explore types of discrimination and gender bias in health care organizations will be presented by Mayo Clinic researchers at the American Society of Clinical Oncology annual meeting in Chicago.
Related topics: Mayo Clinic, Medical Research, Cancer, Oncology

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.